CACCIOLA, Emma
 Distribuzione geografica
Continente #
NA - Nord America 6.242
EU - Europa 4.219
AS - Asia 1.708
AF - Africa 88
SA - Sud America 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.285
Nazione #
US - Stati Uniti d'America 5.802
IE - Irlanda 1.354
UA - Ucraina 1.270
CN - Cina 1.167
IT - Italia 646
CA - Canada 438
SG - Singapore 397
RU - Federazione Russa 342
DE - Germania 152
SE - Svezia 118
FR - Francia 69
GB - Regno Unito 69
CH - Svizzera 55
CI - Costa d'Avorio 55
IN - India 43
VN - Vietnam 34
NL - Olanda 31
UZ - Uzbekistan 23
GR - Grecia 18
AT - Austria 16
NG - Nigeria 16
SN - Senegal 15
BE - Belgio 13
LB - Libano 12
PL - Polonia 12
RO - Romania 12
TW - Taiwan 12
FI - Finlandia 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
EU - Europa 8
AR - Argentina 6
AU - Australia 6
IR - Iran 5
JP - Giappone 4
NZ - Nuova Zelanda 3
PT - Portogallo 3
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
KZ - Kazakistan 2
MK - Macedonia 2
RS - Serbia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
TR - Turchia 1
Totale 12.285
Città #
Dublin 1.350
Jacksonville 1.243
Chandler 983
Ashburn 598
Nanjing 433
Andover 375
Cambridge 368
Lawrence 361
Toronto 352
San Mateo 234
Singapore 217
Des Moines 204
Wilmington 146
Catania 145
Boardman 138
Nanchang 123
Hebei 99
Shenyang 95
Saint Petersburg 85
Ottawa 79
Grafing 77
Jiaxing 75
Changsha 71
Tianjin 69
Abidjan 55
Beijing 36
Moscow 33
Dong Ket 32
Bremen 29
Seattle 27
Norwalk 26
Washington 25
Kunming 23
Pune 23
Den Haag 22
Milan 21
Hangzhou 19
Liberty Lake 19
Ann Arbor 18
Palermo 17
Abuja 16
Dakar 15
Jinan 15
Rome 15
Aci Catena 14
Ningbo 14
Brussels 13
Houston 13
Los Angeles 12
Redwood City 12
Hanover 11
Augusta 10
Frankfurt Am Main 9
Lanzhou 9
Leawood 9
Princeton 9
Taipei 9
Zhengzhou 9
Dearborn 8
Edinburgh 8
Misterbianco 8
Taizhou 8
Helsinki 7
Sofia 7
Trento 7
Wokingham 7
Fairfield 6
Sant'Agata di Militello 6
Viagrande 6
Florence 5
Fuzhou 5
L'hay-les-roses 5
Messina 5
Naples 5
Riposto 5
Santa Venerina 5
Amsterdam 4
Civitavecchia 4
Guangzhou 4
Ludwigshafen 4
Mountain View 4
Mumbai 4
New York 4
Redmond 4
Vittoria 4
Ardabil 3
Auckland 3
Belpasso 3
Buenos Aires 3
Catanzaro 3
Changchun 3
Fremont 3
Hyderabad 3
Lappeenranta 3
Lausanne 3
Lisbon 3
L’Aquila 3
Melbourne 3
Olomouc 3
Padova 3
Totale 8.753
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 409
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 242
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 99
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 66
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 62
Activation of coaugulation and fibrinolysis in laparoscopic surgery 55
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 54
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 54
Activation coagulation and fibrinolysis in laparoscopic surgery 54
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 53
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 53
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 52
A rare case of myeloid sarcoma presenting as anal fissure. 52
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 51
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 51
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 50
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 50
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 50
I disordini dell'emostasi nelle emopatie maligne. 49
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 49
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 49
The antiphospholipid syndrome in pregnancy: a review article 49
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 48
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 48
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 48
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation. 47
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 47
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 47
Activation of coagulation anf fibrinolysis in laparoscopic surgery 47
Le anemie carenziali. 46
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 46
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 46
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 46
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 46
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 46
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 46
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 45
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 45
Unusual onset of severe varicella in adult immunocompromised patients 45
ECLAP Cooperative Group. A Randomized Trial. 45
Interleukin-8 levels in patients with essential thrombocythemia. 45
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 45
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 45
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 44
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 44
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 44
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 44
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 44
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 43
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 43
Thymostimulin in aplastic anaemia. 43
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 42
How to prevent intraoperative risks and complications in laparoscopic splenectomy 42
Thymostimulin in aplastic anaemia and idiopathic thrombocytopenia. 42
Laparoscopic splenectomy: a single center experience 42
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 42
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 42
All-Trans retinoic acid (ATRA) induced apoptosis in peripheral freshly iso- lated chronic myeloid leukemia cells. 42
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 42
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 42
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 42
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 42
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 42
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 42
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 42
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 41
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 41
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 41
JAK2V6176F mutation status and thrombosis in essential thrombocytemia 41
Extra-haematological adverse events in 1075 essential thrombocythemia patients treated with hydroxyurea: a preliminary report of the Registro Italiano Trombocitemia (RIT) 41
Serum overexpresion of interleukin-15 in patients with essential thrombocythemia: which significance? 41
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 41
COVID-19 in Essential Thrombocythemia: Coagulopathy and Thrombosis 41
Increased thromboxane in patients with polycythemia vera and thrombosis: evidence for aspirin-unsuppressible platelet activation in vivo. 41
Immunomodulating treatment in patients with aplastic anemia. 40
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 40
Factor-VIII-rela- ted antigen and vasculitis. 40
The Antiphospholipid Syndrome 40
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 40
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 40
Autologous PBPC infusions may restore T-cells immunosuppression induced by fludarabine in NHL patients trated with fludamitoxantro- ne containing regimen. Preliminary experience. 40
Alpha-Interferon in the myeloproliferative disorders is able to correct the thrombocytosis but not the associated membrane structural and functional platelet abnormalities. 40
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 40
Aspirin-platelet sensotivity in patients with essentila thtombocythemia: role of betafibrinogen G-455-A gene polymorphism 40
Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia 40
Anagrelide treatment in 167 patients with essential thrombocythaemia : a retrospective study of the Italian Group GIMMC 40
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 39
Cutaneous vasculitis in non Hodgkin's Lymphoma. 39
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 39
Effectiveness and safety of combined cytoreductive therapy in 56 patients with essential Thrombocythemia: report of the Regisro Italiano Trombocitemia (RIT) 39
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 39
Effects of anagrelide on platelet and fibrinolytic function in patients with essential thrombocythemia 39
Alteration of endothelium-coagulative system during COPD exacerbations 39
Blood hypercoagulability as a risk factor for leg ulcers in sickle cell disease. 39
Surgical management of hereditary spherocytosis Current strategies 39
Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry 39
Cardiovascular events and intensity of treatment in Polycythemia vera 39
Prothrombin concentration in patients heterozygous for the G20210 and Arg506Gln mutations 38
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients 38
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithronbotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 38
Totale 5.051
Categoria #
all - tutte 43.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 0 0 48
2019/20201.920 806 99 135 7 141 5 98 5 250 18 264 92
2020/20212.008 7 233 274 32 618 26 202 13 316 30 188 69
2021/20222.804 362 401 44 40 442 9 428 95 290 8 67 618
2022/20233.576 376 95 31 238 361 673 6 587 993 29 121 66
2023/20241.682 87 118 78 89 70 170 162 357 18 42 235 256
Totale 12.781